Afuco™ Anti-TNC ADCC Therapeutic Antibody (Tenatumomab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to human Tenascin C/TNC. Tenatumomab is a monoclonal antibody designed for the treatment of cancer.
Supplier Creative Biolabs
Product # AFC-TAB-877
Pricing Inquiry
Host Mouse
Target TNC
Species Reactivity Human
Type ADCC enhanced antibody
Applications FC, IP, ELISA, Neut, FuncS, IF
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback